ABL Bio (XKRX:298380) ROE % Adjusted to Book Value : -3.84% (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ABL Bio ROE % Adjusted to Book Value?

ABL Bio's ROE % for the quarter that ended in Jun. 2024 was -78.03%. ABL Bio's PB Ratio for the quarter that ended in Jun. 2024 was 20.34. ABL Bio's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -3.84%.

ABL Bio ROE % Adjusted to Book Value Historical Data

The historical data trend for ABL Bio's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio ROE % Adjusted to Book Value Chart

ABL Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-3.09

-3.15

-3.19

0.32

-0.23

ABL Bio Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-4.25	-1.79	-3.94	-3.41	-3.84

Competitive Comparison of ABL Bio's ROE % Adjusted to Book Value

For the Biotechnology subindustry, ABL Bio's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ABL Bio's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ABL Bio's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ABL Bio's ROE % Adjusted to Book Value falls into.

ABL Bio ROE % Adjusted to Book Value Calculation

ABL Bio's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-3.69%	/	15.90
	=	-0.23%

ABL Bio's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-78.03%	/	20.34
	=	-3.84%

ABL Bio ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ABL Bio's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488

Website

https://www.ablbio.com

ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio Headlines

No Headlines